tirzepatide doctor philadelphia Board-Certified Physician in Internal Medicine & Weight Loss Specialist Medical Weight Loss Philadelphia -

The challenge is not returning to pre-medication eating habits when these restrictions lift

These findings suggest relevance in research beyond metabolism alone, particularly in exploring endocrine feedback mechanisms

As a result, semaglutide continues to be recognized as the leading GLP-1 option for patients seeking evidence-based, medically supervised weight management in 2026

For an in-person visit, our address is 12462 West Atlantic Boulevard, Coral Springs

Weight-loss drugs like semaglutide may melt fat, but at the cost of muscle mass

For anyone exploring the difference between microdosing tirzepatide and standard dosing, the SURMOUNT data makes it clear that sub-therapeutic doses below 5 mg produce minimal weight loss